Benchmark Reiterates Buy on Beauty Health, Maintains $23 Price Target
Portfolio Pulse from richadhand@benzinga.com
Benchmark analyst Bruce Jackson has reiterated a 'Buy' rating on Beauty Health (NASDAQ:SKIN) and maintained a price target of $23.
August 08, 2023 | 2:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Benchmark analyst Bruce Jackson has reiterated a 'Buy' rating on Beauty Health and maintained a price target of $23.
The reiteration of a 'Buy' rating by a Benchmark analyst and the maintenance of a $23 price target indicates a positive outlook for Beauty Health. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100